IP Library Granted Patent US 10,072,257
Granted Patent B2
US 10,072,257 · App. 14/381,866 · Granted Sep 11, 2018

Inverse patterning process for three-dimensional multi-compartmental micro-organization of multiple cell types

Inventors: Sangeeta N. Bhatia (Lexington, MA); Kelly R. Stevens (Cambridge, MA)
Assignee: Massachusetts Institute of Technology
C12N11/04A61K35/12C12N5/0012C12N5/0062C12N5/0671C12N11/08C12N11/10G01N33/5005C12N2533/76C12N2535/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,072,257
App. No.
14/381,866
Granted
Sep 11, 2018
Kind
B2
Abstract

The invention features an “inverse patterning” or “Intaglio-Void/Embed-Relief Topographic (In VERT) molding” manufacturing process for generating high-resolution three-dimensional (3D) multi-cellular microstructures in distinct cellular compartments of a single hydrogel. The platform has general utility in the development of engineered tissues for human therapies, drug testing, and disease models. Additionally, the platform can serve as a model system for studying 3D cell-cell interactions in fields as diverse as stem cell biology to the development of cancer therapeutics.

Claims (26)

1. A method of making a three-dimensional, multiple cell type tissue construct, comprising

introducing a first population of cells into recessed features of a patterned cell capture substrate;

encapsulating said first cell population in a first polymerizable biomaterial;

polymerizing said first polymerizable biomaterial;

removing and inverting said encapsulated first cell population thereby exposing an inverse pattern of the recessed features containing the first cell population in the first polymerizable biomaterial;

contacting the inverse pattern of the recessed features comprising the, first cell population with a second population of cells in a second polymerizable biomaterial;

encapsulating said second population in said second polymerizable biomaterial; and

polymerizing said second polymerizable biomaterial,

such that the three-dimensional, multiple cell type tissue construct is made.

2. The method of claim 1 , wherein said first population of cells is incubated under conditions sufficient for formation of cell-cell junctions between cells in said features of said patterned cell capture substrate prior to encapsulating said first cell population in said first polymerizable biomaterial.

3. The method of claim 1 , wherein the patterned cell capture substrate consists of polydimethyl siloxane (PDMS) comprising micro-scale features.

4. The method of claim 1 , wherein the first population of cells is introduced into the features of the patterned cell capture substrate in a media or pre-polymer solution.

5. The method of claim 1 , wherein said first population of cells is incubated for a period of about 6 to about 24 hours, to permit formation of cell-cell junctions between said cells.

6. The method of claim 1 , wherein said first and/or second polymerizable biomaterial is a hydrogel material.

7. The method of claim 6 , wherein the hydrogel material is agarose, fibrin, or polyethylene hydrogel.

8. The method of claim 7 , wherein the hydrogel material is photopolymerized polyethylene glycol (PEG) hydrogel.

9. The method of claim 1 , wherein the first or second cell population, or both the first and second cell populations comprise parenchymal cells.

10. The method of claim 1 , wherein the first or second cell population, or both the first and second cell populations comprise non-parenchymal cells.

11. The method of claim 1 , wherein the first or second cell population, or both the first and second cell populations comprise a combination of parenchymal and non-parenchymal cells.

12. The method of claim 9 , wherein the parenchymal cells are human parenchymal cells.

13. The method of claim 5 , wherein the hydrogel is derivatized with one or more cell-adhesive peptides, or comprises one or more soluble factors supporting cell growth and/or differentiation.

14. The method of claim 1 , wherein the first or second cell populations, or both the first and second cell populations are encapsulated at a concentration of from about 8×10 6 cells/ml to about 24×10 6 cells/ml.

15. The method of claim 1 , wherein the polymerizable biomaterial is biodegradable.

16. The method of claim 1 , wherein one or more of the populations of cells is engineered to express a reporter protein.

17. The method of claim 1 , wherein said first population of cells is incubated for a period of about 8 to about 16 hours to permit formation of cell-cell junctions between said cells.

18. The method of claim 1 , wherein said first population of cells is incubated for a period of about 12 hours to permit formation of cell-cell junctions between said cells.

Assignments (5)
CONFIRMATION OF ASSIGNMENT Recorded Sep 22, 2016
From: BHATIA, SANGEETA N.
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 040107/0698 →
APPOINTMENT OF INVESTIGATOR AS AGENT Recorded Sep 22, 2016
From: HOWARD HUGHES MEDICAL INSTITUTE
To: BHATIA, SANGEETA N.
Reel/Frame 040107/0740 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2016
From: STEVENS, KELLY R.
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 039766/0540 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2015
From: BHATIA, SANGEETA N.
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 037134/0036 →
CONFIRMATORY LICENSE Recorded Jun 2, 2015
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035814/0007 →
Continuity (3)
Provisional Application 61619074 · Apr 2, 2012
Provisional Application 61604841 · Feb 29, 2012
Related Publication 20150082468A1 · Mar 19, 2015
Cited By (8)
US 12,303,892 US 12,440,837 US 12,569,847 US 12,576,399 US 12,576,400 US 12,642,890 US 12,661,647 US 12,714,996